Skip to content
No Vape

A quitting study used a historical control: which comparison was made?

Separate earlier external records from a concurrent comparison and retain the calendar and measurement differences the report describes.

No Vape · Updated

Disposable vape resting on concrete
Illustrative image · Markus Winkler / Unsplash

Locate the control population rather than imagining one

Find where the comparison information came from: an earlier study, a service record or another defined source. Ask whether the investigators selected particular people or used a published summary. If the comparator is only a general expected quit rate, do not silently turn it into a matched participant group.

The final 2001 ICH E10 document hosted by FDA distinguishes external controls, including groups observed earlier, from internal concurrent controls. Its terminology supports this reading task. It is not current treatment advice, an FDA decision about a vaping program or a claim that all historical comparisons are equally informative.

US Food and Drug Administration / International Council for Harmonisation: ICH E10: Choice of Control Group and Related Issues in Clinical Trials (2001)

Put the two time periods next to the two populations

Make one row per source with dates, entry criteria, starting point and outcome window. Similar ages alone do not establish comparable groups. The available support, recruitment route, product context or recording practices could differ. Record what the report actually documents instead of assigning a convenient explanation.

In an invented example, a new adult planning service compares its current follow-up with an older service’s published summary. The new service may have different participants and a different follow-up question. A difference between the summaries is not automatically the effect of the new planning format. No actual program or quit rate is described here.

Check measurement and follow-up on both sides

A shared outcome label can conceal different definitions or observation windows. Ask how the outcome was obtained, which participants contributed it and what happened to missing observations. The older source might lack variables needed for the comparison; their absence remains a limitation, not evidence that the populations were identical.

ICH E10 explains that external groups can differ in background and observation conditions, including unmeasured factors. That is a reason to retain the report’s comparability limitations. It does not allow a reader to decide the direction or size of bias from the label alone.

US Food and Drug Administration / International Council for Harmonisation: ICH E10: Choice of Control Group and Related Issues in Clinical Trials (2001)

Keep adjustment separate from random assignment

Researchers may match or adjust for recorded differences. Read what they actually used and what remains unmeasured. A statistical method does not create a contemporaneous randomized group or make unavailable historical information appear. Do not dismiss the method merely because it is not randomization, either.

A concurrent external group is another possible arrangement: outside the study but observed in the same period. That differs from an earlier historical group. Describe the actual combination when both are present rather than using external and historical as universally interchangeable words.

Carry provenance into the conclusion

A careful summary identifies that the comparison used this earlier source with these stated limitations. Avoid restating a numerical difference as a guaranteed personal benefit. Conversely, the existence of a historical control is not by itself a verdict that the authors acted improperly.

This reading map is not a formal appraisal or a new analysis. Qualified interpretation is appropriate for health decisions. Its useful result is knowing who supplied the comparison, when they were observed and why a controlled label cannot substitute for those details.

Sources and scope

Sources inform the guidance. The worksheets and examples are No Vape editorial suggestions, not tested treatments.

  1. US Food and Drug Administration / International Council for Harmonisation — ICH E10: Choice of Control Group and Related Issues in Clinical Trials (2001)
  2. No Vape — No Vape — app features and store links

Written with AI assistance and checked against the cited sources. No clinical review is claimed. This guide covers practical planning, not individual medical treatment. How we research and write